Impaired function of regulatory T-cells in patients with chronic obstructive pulmonary disease (COPD)

Immunobiology

Volumn 219, Issue 12, 2014, Pages 975-979

  Tan, Dino B A ^a,b   Fernandez, Sonia ^a   Price, Patricia ^a   French, Martyn A ^a,c   Thompson, Philip J ^a,b   Moodley, Yuben P ^a,b,c  

^a UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^b UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^c ROYAL PERTH HOSPITAL   (Australia)

Author keywords

Anti inflammatory; COPD; Foxp3; Obesity; Regulatory T cells

Indexed keywords

HLA DR ANTIGEN; BIOLOGICAL MARKER;

ADULT; AGED; ANTIGEN EXPRESSION; ARTICLE; BODY MASS; CD4+ T LYMPHOCYTE; CELL ISOLATION; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE RELEASE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FLUORESCENCE ACTIVATED CELL SORTING; HUMAN; HUMAN CELL; IMMUNOPHENOTYPING; LYMPHOCYTE ACTIVATION; MALE; MIDDLE AGED; PATHOGENESIS; PERIPHERAL BLOOD MONONUCLEAR CELL; REGULATORY T LYMPHOCYTE; VERY ELDERLY; BLOOD; CASE CONTROL STUDY; IMMUNOLOGY; LYMPHOCYTE DEPLETION; METABOLISM; MONONUCLEAR CELL; PATHOPHYSIOLOGY; PHENOTYPE; RISK FACTOR; T LYMPHOCYTE SUBPOPULATION;

AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; FEMALE; HUMANS; IMMUNOPHENOTYPING; LEUKOCYTES, MONONUCLEAR; LYMPHOCYTE ACTIVATION; LYMPHOCYTE DEPLETION; MALE; MIDDLE AGED; PHENOTYPE; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RISK FACTORS; T-LYMPHOCYTE SUBSETS; T-LYMPHOCYTES, REGULATORY;

EID: 84912523793     PISSN: 01712985     EISSN: 18783279     Source Type: Journal    
DOI: 10.1016/j.imbio.2014.07.005     Document Type: Article

References (32)

1. Alcorn J.F., Crowe C.R., Kolls J.K. TH17 cells in asthma and COPD. Annu. Rev. Physiol. 2010, 72:495-516.
2. Barcelo B., Pons J., Ferrer J.M., Sauleda J., Fuster A., Agusti A.G. Phenotypic characterisation of T-lymphocytes in COPD: abnormal CD4+CD25+ regulatory T-lymphocyte response to tobacco smoking. Eur. Respir. J. 2008, 31:555-562.
3. Barnes P.J., Celli B.R. Systemic manifestations and comorbidities of COPD. Eur. Respir. J. 2009, 33:1165-1185.
4. Chrysofakis G., Tzanakis N., Kyriakoy D., Tsoumakidou M., Tsiligianni I., Klimathianaki M., Siafakas N.M. Perforin expression and cytotoxic activity of sputum CD8+ lymphocytes in patients with COPD. Chest 2004, 125:71-76.
5. Chu S., Zhong X., Zhang J., Lao Q., He Z., Bai J. The expression of Foxp3 and ROR gamma t in lung tissues from normal smokers and chronic obstructive pulmonary disease patients. Int. Immunopharmacol. 2011.
6. Chu S., Zhong X., Zhang J., Lao Q., He Z., Bai J. The expression of Foxp3 and ROR gamma t in lung tissues from normal smokers and chronic obstructive pulmonary disease patients. Int. Immunopharmacol. 2011, 11:1780-1788.
7. Cosio M.G., Saetta M., Agusti A. Immunologic aspects of chronic obstructive pulmonary disease. N. Engl. J. Med. 2009, 360:2445-2454.
8. Di Stefano A., Caramori G., Gnemmi I., Contoli M., Vicari C., Capelli A., Magno F., D'Anna S.E., Zanini A., Brun P., Casolari P., Chung K.F., Barnes P.J., Papi A., Adcock I., Balbi B. T helper type 17-related cytokine expression is increased in the bronchial mucosa of stable chronic obstructive pulmonary disease patients. Clin. Exp. Immunol. 2009, 157:316-324.
9. Finney O.C., Riley E.M., Walther M. Phenotypic analysis of human peripheral blood regulatory T cells (CD4+FOXP3+CD127lo/-) ex vivo and after in vitro restimulation with malaria antigens. Eur. J. Immunol. 2010, 40:47-60.
10. Han J.M., Patterson S.J., Speck M., Ehses J.A., Levings M.K. Insulin inhibits IL-10-mediated regulatory T cell function: implications for obesity. J. Immunol. 2014, 192:623-629.
11. Hogg J.C., Chu F., Utokaparch S., Woods R., Elliott W.M., Buzatu L., Cherniack R.M., Rogers R.M., Sciurba F.C., Coxson H.O., Pare P.D. The nature of small-airway obstruction in chronic obstructive pulmonary disease. N. Engl. J. Med. 2004, 350:2645-2653.
12. Hou J., Sun Y., Hao Y., Zhuo J., Liu X., Bai P., Han J., Zheng X., Zeng H. Imbalance between subpopulations of regulatory T cells in COPD. Thorax 2013, 68:1131-1139.
13. Isajevs S., Taivans I., Strazda G., Kopeika U., Bukovskis M., Gordjusina V., Kratovska A. Decreased FOXP3 expression in small airways of smokers with COPD. Eur. Respir. J. 2009, 33:61-67.
14. Liu W., Putnam A.L., Xu-Yu Z., Szot G.L., Lee M.R., Zhu S., Gottlieb P.A., Kapranov P., Gingeras T.R., Fazekas de St Groth B., Clayberger C., Soper D.M., Ziegler S.F., Bluestone J.A. CD127 expression inversely correlates with FoxP3 and suppressive function of human CD4+ T reg cells. J. Exp. Med. 2006, 203:1701-1711.
15. Majo J., Ghezzo H., Cosio M.G. Lymphocyte population and apoptosis in the lungs of smokers and their relation to emphysema. Eur. Respir. J. 2001, 17:946-953.
16. Mannino D.M., Homa D.M., Akinbami L.J., Ford E.S., Redd S.C. Chronic obstructive pulmonary disease surveillance - United States, 1971-2000. Respir. Care 2002, 47:1184-1199.
17. Matarese G., Procaccini C., De Rosa V., Horvath T.L., La Cava A. Regulatory T cells in obesity: the leptin connection. Trends Mol. Med. 2010, 16:247-256.
18. Miyara M., Yoshioka Y., Kitoh A., Shima T., Wing K., Niwa A., Parizot C., Taflin C., Heike T., Valeyre D., Mathian A., Nakahata T., Yamaguchi T., Nomura T., Ono M., Amoura Z., Gorochov G., Sakaguchi S. Functional delineation and differentiation dynamics of human CD4+ T cells expressing the FoxP3 transcription factor. Immunity 2009, 30:899-911.
19. Paats M.S., Bergen I.M., Hoogsteden H.C., van der Eerden M.M., Hendriks R.W. Systemic CD4+ and CD8+ T-cell cytokine profiles correlate with GOLD stage in stable COPD. Eur. Respir. J. 2011, 40:330-337.
20. Plumb J., Smyth L.J., Adams H.R., Vestbo J., Bentley A., Singh S.D. Increased T-regulatory cells within lymphocyte follicles in moderate COPD. Eur. Respir. J. 2009, 34:89-94.
21. Profita M., Albano G.D., Riccobono L., Di Sano C., Montalbano A.M., Gagliardo R., Anzalone G., Bonanno A., Pieper M.P., Gjomarkaj M. Increased levels of Th17 cells are associated with non-neuronal acetylcholine in COPD patients. Immunobiology 2014, 219:392-401.
22. Rabe K.F., Hurd S., Anzueto A., Barnes P.J., Buist S.A., Calverley P., Fukuchi Y., Jenkins C., Rodriguez-Roisin R., van Weel C., Zielinski J. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am. J. Respir. Crit. Care Med. 2007, 176:532-555.
23. Rivera R.M., Cosio M.G., Ghezzo H., Salazar M., Perez-Padilla R. Comparison of lung morphology in COPD secondary to cigarette and biomass smoke. Int. J. Tuberc. Lung Dis. 2008, 12:972-977.
24. Roos-Engstrand E., Ekstrand-Hammarstrom B., Pourazar J., Behndig A.F., Bucht A., Blomberg A. Influence of smoking cessation on airway T lymphocyte subsets in COPD. COPD 2009, 6:112-120.
25. Sakaguchi S., Wing K., Yamaguchi T. Dynamics of peripheral tolerance and immune regulation mediated by Treg. Eur. J. Immunol. 2009, 39:2331-2336.
26. Seddiki N., Santner-Nanan B., Martinson J., Zaunders J., Sasson S., Landay A., Solomon M., Selby W., Alexander S.I., Nanan R., Kelleher A., Fazekas de St Groth B. Expression of interleukin (IL)-2 and IL-7 receptors discriminates between human regulatory and activated T cells. J. Exp. Med. 2006, 203:1693-1700.
27. Sinden N.J., Stockley R.A. Systemic inflammation and comorbidity in COPD: a result of 'overspill' of inflammatory mediators from the lungs? Review of the evidence. Thorax 2010, 65:930-936.
28. Smyth L.J., Starkey C., Vestbo J., Singh D. CD4-regulatory cells in COPD patients. Chest 2007, 132:156-163.
29. Takabatake N., Nakamura H., Abe S., Inoue S., Hino T., Saito H., Yuki H., Kato S., Tomoike H. The relationship between chronic hypoxemia and activation of the tumor necrosis factor-alpha system in patients with chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 2000, 161:1179-1184.
30. Vargas-Rojas M.I., Ramirez-Venegas A., Limon-Camacho L., Ochoa L., Hernandez-Zenteno R., Sansores R.H. Increase of Th17 cells in peripheral blood of patients with chronic obstructive pulmonary disease. Respir. Med. 2011, 105:1648-1654.
31. Wagner N.M., Brandhorst G., Czepluch F., Lankeit M., Eberle C., Herzberg S., Faustin V., Riggert J., Oellerich M., Hasenfuss G., Konstantinides S., Schafer K. Circulating regulatory T cells are reduced in obesity and may identify subjects at increased metabolic and cardiovascular risk. Obesity (Silver Spring) 2013, 21:461-468.
32. Walker L.S., Sansom D.M. The emerging role of CTLA4 as a cell-extrinsic regulator of T cell responses. Nat. Rev. Immunol. 2011, 11:852-863.